We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$703M
AUM Growth
-$959K
Cap. Flow
-$27.3M
Cap. Flow %
-3.89%
Top 10 Hldgs %
67.63%
Holding
70
New
23
Increased
4
Reduced
11
Closed
1

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$2.77M
2
WAB icon
Wabtec
WAB
+$1.96M
3
DBVT
DBV Technologies
DBVT
+$1.02M
4
AMAG
AMAG Pharmaceuticals
AMAG
+$958K
5
GILD icon
Gilead Sciences
GILD
+$893K

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$13.5M
2
NOV icon
NOV
NOV
+$7.05M
3
PSX icon
Phillips 66
PSX
+$6.59M
4
DE icon
Deere & Co
DE
+$5.19M
5
XOM icon
ExxonMobil
XOM
+$2.51M

Sector Composition

Rank Sector Weight
1 Financials 40.44%
2 Healthcare 21.67%
3 Technology 15.98%
4 Industrials 9.65%
5 Energy 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$30.1B
$6.01M 0.86%
22,000
-3,000
-12% -$848K
ISRG icon
27
Intuitive Surgical
ISRG
$142B
$5.96M 0.85%
69,930
– –
USB icon
28
US Bancorp
USB
$100B
$5.81M 0.83%
112,900
– –
BDX icon
29
Becton Dickinson
BDX
$49.4B
$4.18M 0.6%
23,370
-5,433
-19% -$947K
MDT icon
30
Medtronic
MDT
$116B
$4.08M 0.58%
50,700
-12,300
-20% -$961K
BMY icon
31
Bristol-Myers Squibb
BMY
$130B
$3.74M 0.53%
68,700
– –
GILD icon
32
Gilead Sciences
GILD
$168B
$3.51M 0.5%
51,700
+12,700
+33% +$893K
GOOG icon
33
Alphabet (Google) Class C
GOOG
$4.19T
$3.23M 0.46%
78,000
– –
UTHR icon
34
United Therapeutics
UTHR
$22.1B
$2.69M 0.38%
19,900
– –
ACAD icon
35
Acadia Pharmaceuticals
ACAD
$5.07B
$2.06M 0.29%
60,000
– –
KO icon
36
Coca-Cola
KO
$372B
$1.95M 0.28%
46,000
– –
WAB icon
37
Wabtec
WAB
$50.3B
$1.85M 0.26%
+23,700
New +$1.96M
DO
38
DELISTED
Diamond Offshore Drilling
DO
$1.84M 0.26%
109,900
– –
KHC icon
39
Kraft Heinz
KHC
$29.2B
$1.75M 0.25%
19,320
– –
AXP icon
40
American Express
AXP
$230B
$1.39M 0.2%
17,600
– –
MCD icon
41
McDonald's
MCD
$194B
$1.3M 0.19%
10,060
– –
MA icon
42
Mastercard
MA
$492B
$1.13M 0.16%
10,000
– –
BUD icon
43
AB InBev
BUD
$159B
$1.11M 0.16%
10,100
+4,100
+68% +$441K
LGND icon
44
Ligand Pharmaceuticals
LGND
$5.76B
$1.06M 0.15%
16,030
– –
DBVT
45
DBV Technologies
DBVT
$885M
$1.03M 0.15%
+2,912
New +$1.02M
DNOW icon
46
DNOW Inc
DNOW
$3.01B
$944K 0.13%
55,675
– –
TFCF
47
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$925K 0.13%
+29,100
New +$874K
AMAG
48
DELISTED
AMAG Pharmaceuticals
AMAG
$902K 0.13%
+40,000
New +$958K
OPK icon
49
Opko Health
OPK
$1.04B
$715K 0.1%
+89,405
New +$753K
TGTX icon
50
TG Therapeutics
TGTX
$7.64B
$699K 0.1%
+60,000
New +$431K
1
2
3

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q1 2017 Portfolio in Review

As of Q1 2017, Hikari Power held 70 positions worth $703M, down 0.14% from $704M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Hikari Power withdrew a net $27.3M in Q1 2017, closing 1 position and reducing 11 holdings. Its most notable exit was Deere & Co, an estimated $5.19M position sold in full.

By sector, the portfolio is most concentrated in Financials at 40% of assets, down from 41% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Hikari Power opened a new position in Wabtec worth $1.85M.

  • Hikari Power's largest Q1 2017 buy was Wabtec: 23,700 shares worth $1.85M.
  • Hikari Power added most to Allergan plc in Q1 2017, an estimated $2.77M increase.
  • Hikari Power's biggest Q1 2017 reduction was Wells Fargo, cutting an estimated $13.5M.
  • Hikari Power fully exited Deere & Co in Q1 2017, selling an estimated $5.19M.
  • Hikari Power's ten largest holdings make up 68% of its $703M portfolio in Q1 2017.
  • Hikari Power opened 23 new positions and closed 1 in Q1 2017.
  • Hikari Power's portfolio value fell 0.14% quarter-over-quarter to $703M.

Based on Hikari Power's 13F filing for Q1 2017, filed 26 Apr 2017.